Forte Biosciences Inc
F:37TA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Forte Biosciences Inc
F:37TA
|
US |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
F:MUV2
|
DE |
|
Cooper Companies Inc
F:CP60
|
US |
|
London Stock Exchange Group PLC
LSE:LSEG
|
UK |
|
4
|
4C Group AB
F:K0E
|
SE |
|
DSV A/S
F:DS81
|
DK |
|
I
|
Interpublic Group of Companies Inc
SWB:IPG
|
US |
|
H
|
Healthcare Realty Trust Inc
F:HR6
|
US |
|
Orell Fuessli AG
F:OFH
|
CH |
|
Barratt Developments P L C
LSE:BDEV
|
UK |
|
TBS Holdings Inc
OTC:TKOBF
|
JP |
|
N
|
NXP Semiconductors NV
XMUN:VNX
|
NL |
|
N
|
Nordstrom Inc
F:NRD
|
US |
|
I
|
Interpublic Group of Companies Inc
XMUN:IPG
|
US |
|
R
|
Roper Technologies Inc
NASDAQ:ROP
|
US |
Wall St Price Targets
37TA Price Targets Summary
Forte Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
37TA is 6.65 EUR with a low forecast of 5.44 EUR and a high forecast of 7.14 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 37TA's stock price target?
Price Target
6.65
EUR
According to Wall Street analysts, the average 1-year price target for
37TA is 6.65 EUR with a low forecast of 5.44 EUR and a high forecast of 7.14 EUR.